PTK2 and colonic neoplasm: Resveratrol-mediated antitumor effects are enhanced by inhibition of FAK and cytoskeleton proteins, as demonstrated in human colorectal cancer SW480 and HCT116 cell lines (5 μM) [214] and in the colon cancer HT29 cell line (100 μM) [215].